Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression

Linda J. Addonizio, Daphne T. Hsu, Judith F. Douglas, Maryanne R. Kichuk, Robert E. Michler, Jan M. Quaegebeur, Craig R. Smith, Eric A. Rose

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background. Coronary artery disease (CAD) is a limiting factor to long-term survival in cardiac transplant recipients, affecting from 30% to 50% of patients by 5 years after surgery. Can the incidence of CAD be lowered with augmentation of immunosuppression? Methods and Results. We compared the incidence of CAD in our pediatric transplant population with nine potential risk factors, including immunosuppressive regimen. The study group consisted of 55 patients who survived more than 1 year (or to first angiogram) or had autopsies. Coronary angiograms were performed yearly and compared sequentially. The mean follow-up of 55 patients was 36 months. Mean age was 10.3±6 years (range, 4 months to 18 years). Thirteen patients received double immunosuppression with cyclosporine and prednisone, and 42 received triple therapy with cyclosporine, prednisone, and azathioprine. Significant CAD occurred in 10 grafts (6 deaths and 3 retransplants). Cause for graft loss in 6 patients with CAD was acute rejection. CAD was detected by angiogram in only 2 patients. Nine of 10 patients received double therapy (P<.001). There was no difference in mean follow-up between immunosuppression groups. There was a higher rejection frequency for double therapy (0.19±0.16 rejections per patient month) compared with triple therapy (0.07±0.11). Ten patients were rejection free in the triple therapy group. Conclusions. We experienced a significant decrease in the incidence of CAD in our pediatric cardiac transplant recipients using increased immunosuppressive therapy. Type of immunosuppressive regimen (double) and rejection frequency were independent predictors for CAD by multivariate analysis.

Original languageEnglish (US)
Pages (from-to)224-229
Number of pages6
JournalCirculation
Volume88
Issue number5 PART 2
StatePublished - Nov 1993
Externally publishedYes

Fingerprint

Immunosuppression
Coronary Disease
Coronary Artery Disease
Pediatrics
Incidence
Immunosuppressive Agents
Angiography
Prednisone
Transplants
Cyclosporine
Therapeutics
Transplant Recipients
Azathioprine
Group Psychotherapy
Autopsy
Multivariate Analysis
Rejection (Psychology)
Survival
Population

Keywords

  • Coronary artery disease
  • Drugs
  • Pediatrics
  • Transplant

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Addonizio, L. J., Hsu, D. T., Douglas, J. F., Kichuk, M. R., Michler, R. E., Quaegebeur, J. M., ... Rose, E. A. (1993). Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. Circulation, 88(5 PART 2), 224-229.

Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. / Addonizio, Linda J.; Hsu, Daphne T.; Douglas, Judith F.; Kichuk, Maryanne R.; Michler, Robert E.; Quaegebeur, Jan M.; Smith, Craig R.; Rose, Eric A.

In: Circulation, Vol. 88, No. 5 PART 2, 11.1993, p. 224-229.

Research output: Contribution to journalArticle

Addonizio, LJ, Hsu, DT, Douglas, JF, Kichuk, MR, Michler, RE, Quaegebeur, JM, Smith, CR & Rose, EA 1993, 'Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression', Circulation, vol. 88, no. 5 PART 2, pp. 224-229.
Addonizio, Linda J. ; Hsu, Daphne T. ; Douglas, Judith F. ; Kichuk, Maryanne R. ; Michler, Robert E. ; Quaegebeur, Jan M. ; Smith, Craig R. ; Rose, Eric A. / Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. In: Circulation. 1993 ; Vol. 88, No. 5 PART 2. pp. 224-229.
@article{d6f893bb459748afa3a995b7ec627e1f,
title = "Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression",
abstract = "Background. Coronary artery disease (CAD) is a limiting factor to long-term survival in cardiac transplant recipients, affecting from 30{\%} to 50{\%} of patients by 5 years after surgery. Can the incidence of CAD be lowered with augmentation of immunosuppression? Methods and Results. We compared the incidence of CAD in our pediatric transplant population with nine potential risk factors, including immunosuppressive regimen. The study group consisted of 55 patients who survived more than 1 year (or to first angiogram) or had autopsies. Coronary angiograms were performed yearly and compared sequentially. The mean follow-up of 55 patients was 36 months. Mean age was 10.3±6 years (range, 4 months to 18 years). Thirteen patients received double immunosuppression with cyclosporine and prednisone, and 42 received triple therapy with cyclosporine, prednisone, and azathioprine. Significant CAD occurred in 10 grafts (6 deaths and 3 retransplants). Cause for graft loss in 6 patients with CAD was acute rejection. CAD was detected by angiogram in only 2 patients. Nine of 10 patients received double therapy (P<.001). There was no difference in mean follow-up between immunosuppression groups. There was a higher rejection frequency for double therapy (0.19±0.16 rejections per patient month) compared with triple therapy (0.07±0.11). Ten patients were rejection free in the triple therapy group. Conclusions. We experienced a significant decrease in the incidence of CAD in our pediatric cardiac transplant recipients using increased immunosuppressive therapy. Type of immunosuppressive regimen (double) and rejection frequency were independent predictors for CAD by multivariate analysis.",
keywords = "Coronary artery disease, Drugs, Pediatrics, Transplant",
author = "Addonizio, {Linda J.} and Hsu, {Daphne T.} and Douglas, {Judith F.} and Kichuk, {Maryanne R.} and Michler, {Robert E.} and Quaegebeur, {Jan M.} and Smith, {Craig R.} and Rose, {Eric A.}",
year = "1993",
month = "11",
language = "English (US)",
volume = "88",
pages = "224--229",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5 PART 2",

}

TY - JOUR

T1 - Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression

AU - Addonizio, Linda J.

AU - Hsu, Daphne T.

AU - Douglas, Judith F.

AU - Kichuk, Maryanne R.

AU - Michler, Robert E.

AU - Quaegebeur, Jan M.

AU - Smith, Craig R.

AU - Rose, Eric A.

PY - 1993/11

Y1 - 1993/11

N2 - Background. Coronary artery disease (CAD) is a limiting factor to long-term survival in cardiac transplant recipients, affecting from 30% to 50% of patients by 5 years after surgery. Can the incidence of CAD be lowered with augmentation of immunosuppression? Methods and Results. We compared the incidence of CAD in our pediatric transplant population with nine potential risk factors, including immunosuppressive regimen. The study group consisted of 55 patients who survived more than 1 year (or to first angiogram) or had autopsies. Coronary angiograms were performed yearly and compared sequentially. The mean follow-up of 55 patients was 36 months. Mean age was 10.3±6 years (range, 4 months to 18 years). Thirteen patients received double immunosuppression with cyclosporine and prednisone, and 42 received triple therapy with cyclosporine, prednisone, and azathioprine. Significant CAD occurred in 10 grafts (6 deaths and 3 retransplants). Cause for graft loss in 6 patients with CAD was acute rejection. CAD was detected by angiogram in only 2 patients. Nine of 10 patients received double therapy (P<.001). There was no difference in mean follow-up between immunosuppression groups. There was a higher rejection frequency for double therapy (0.19±0.16 rejections per patient month) compared with triple therapy (0.07±0.11). Ten patients were rejection free in the triple therapy group. Conclusions. We experienced a significant decrease in the incidence of CAD in our pediatric cardiac transplant recipients using increased immunosuppressive therapy. Type of immunosuppressive regimen (double) and rejection frequency were independent predictors for CAD by multivariate analysis.

AB - Background. Coronary artery disease (CAD) is a limiting factor to long-term survival in cardiac transplant recipients, affecting from 30% to 50% of patients by 5 years after surgery. Can the incidence of CAD be lowered with augmentation of immunosuppression? Methods and Results. We compared the incidence of CAD in our pediatric transplant population with nine potential risk factors, including immunosuppressive regimen. The study group consisted of 55 patients who survived more than 1 year (or to first angiogram) or had autopsies. Coronary angiograms were performed yearly and compared sequentially. The mean follow-up of 55 patients was 36 months. Mean age was 10.3±6 years (range, 4 months to 18 years). Thirteen patients received double immunosuppression with cyclosporine and prednisone, and 42 received triple therapy with cyclosporine, prednisone, and azathioprine. Significant CAD occurred in 10 grafts (6 deaths and 3 retransplants). Cause for graft loss in 6 patients with CAD was acute rejection. CAD was detected by angiogram in only 2 patients. Nine of 10 patients received double therapy (P<.001). There was no difference in mean follow-up between immunosuppression groups. There was a higher rejection frequency for double therapy (0.19±0.16 rejections per patient month) compared with triple therapy (0.07±0.11). Ten patients were rejection free in the triple therapy group. Conclusions. We experienced a significant decrease in the incidence of CAD in our pediatric cardiac transplant recipients using increased immunosuppressive therapy. Type of immunosuppressive regimen (double) and rejection frequency were independent predictors for CAD by multivariate analysis.

KW - Coronary artery disease

KW - Drugs

KW - Pediatrics

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=0027515105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027515105&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 224

EP - 229

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 5 PART 2

ER -